Artificial Intelligence in Regulatory Affairs for Growing Pharmaceutical Companies

Abstract

Healthcare product development is about to undergo a drastic change because of artificial intelligence (AI), which has the potential to greatly benefit patients as well as other stakeholders like regulators and industry. One of the most significant factors contributing to this development is the capacity of AI applications to handle routine logical problems and procedural difficulties faced by compliance officers. AI can quickly and accurately manage enormous amounts of information, which may theoretically enhance regulatory compliance. It is safe to claim that technology will soon enable manufacturers to understand compliance requirements quickly and take the necessary actions. Finally, the sustained application of AI in the regulatory and legal sectors has the potential to drastically reduce the number of individuals required to execute the operations. The numerous AI applications are growing rapidly in how organizations are promoting innovation and developing their business strategies. AI has streamlined and had numerous positive effects on the pharmaceutical industry throughout the years, from developing new and improved medications to treating rare disorders. In this article, examples of companies using AI technology are mentioned.